FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jacek Kiljanski

Research Profile

Disorders

Chemicals & Drugs

Anatomy

Co-author Network

Publications

TOP 3
Claes-Göran Ostenson; Matthew Reaney; Carole Salaun-Martin; Hélène Sapin; David Bruhn; Bruno Guerci; Jacek Kiljanski; Thure Krarup; Chantal Mathieu; Stephan Matthaei; Michael Theodorakis
Treatment outcomes after initiation of exenatide twice daily or insulin in clinical practice: 12-month results from CHOICE in six European countries.
Stephan Matthaei; Claes-Göran Ostenson; Helmut Petto; Matthew Reaney; David Bruhn; Bruno Guerci; Jacek Kiljanski; Thure Krarup; Chantal Mathieu; Michael Theodorakis
Patients with Type 2 Diabetes Initiating Exenatide Twice Daily or Insulin in Clinical Practice: CHOICE Study.
Tibor Iványi; Péter Faludi; József Fövényi; Jenny Han; Leigh Macconell; Simone Wille; Jacek Kiljanski
Long-term effects of adding exenatide to a regimen of metformin and/or sulfonylurea in type 2 diabetes: an uncontrolled, open-label trial in Hungary.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jacek Kiljanski (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Claes-Göran Ostenson; Matthew Reaney; Carole Salaun-Martin; Hélène Sapin; David Bruhn; Bruno Guerci; Jacek Kiljanski; Thure Krarup; Chantal Mathieu; Stephan Matthaei; Michael Theodorakis
Treatment outcomes after initiation of exenatide twice daily or insulin in clinical practice: 12-month results from CHOICE in six European countries.
Diabetes, metabolic syndrome and obesity : targets and therapy 2013;6():171-85.
2012: Stephan Matthaei; Claes-Göran Ostenson; Helmut Petto; Matthew Reaney; David Bruhn; Bruno Guerci; Jacek Kiljanski; Thure Krarup; Chantal Mathieu; Michael Theodorakis
Patients with Type 2 Diabetes Initiating Exenatide Twice Daily or Insulin in Clinical Practice: CHOICE Study.
Diabetes therapy : research, treatment and education of diabetes and related disorders 2012;3(1):6.
2012: Tibor Iványi; Péter Faludi; József Fövényi; Jenny Han; Leigh Macconell; Simone Wille; Jacek Kiljanski
Long-term effects of adding exenatide to a regimen of metformin and/or sulfonylurea in type 2 diabetes: an uncontrolled, open-label trial in Hungary.
Clinical therapeutics 2012;34(6):1301-13.
2011: Eugenia Farcasiu; Tibor Ivanyi; Irina Kowalska; Barbara Mozejko-Pastewka; Birgit Schinzel; Zita Birkus; Sami Bulgurlu; Thomas Frederic Coetzer; Jozsef Csog; Jacek Kiljanski
Efficacy and safety of prandial premixed therapy using insulin lispro mix 50/50 3 times daily compared with progressive titration of insulin lispro mix 75/25 or biphasic insulin aspart 70/30 twice daily in patients with type 2 diabetes mellitus: a randomized, 16-week, open-label study.
Clinical therapeutics 2011;33(11):1682-93.
2009: Eleazar Shafrir; Maciej T Malecki; Barbara Mozejko-Pastewka; Jacek Kiljanski
Proceedings of the 8th Regional Medical Conference on the treatment of type 2 diabetes mellitus. Introduction.
Diabetes research and clinical practice 2009;86 Suppl 1():S1.
2008: Eleazar Shafrir; Maciej Malecki; Guntram Schernthaner; Jacek Kiljanski
Treatment of type 2 diabetes mellitus. Introduction.
Diabetes research and clinical practice 2008;82 Suppl 2():S81-2.
1998: K Gunji; S Kubota; J Swanson; Jacek Kiljanski; Tomasz Bednarczuk; S Wengrowicz; Mario Salvi; Jack R Wall
Role of the eye muscles in thyroid eye disease: identification of the principal autoantigens.
Thyroid : official journal of the American Thyroid Association 1998;8(6):553-6.
1998: Tomasz Bednarczuk; Jacek Kiljanski; T Mrowiec; Milena Slon; EB Ing; Carol Stolarski; John S Kennerdell; A Gorski; Janusz Nauman; Jack R Wall
T cell interactions with extracellular matrix proteins in patients with thyroid-associated ophthalmopathy.
Autoimmunity 1998;27(4):221-30.
1997: Jacek Kiljanski; K Peele; I Stachura; J Pickeral; Carol Stolarski; John S Kennerdell; Jack R Wall
Antibodies against striated muscle, connective tissue and nuclear antigens in patients with thyroid-associated ophthalmopathy: should Graves' disease be considered a collagen disorder?
Journal of endocrinological investigation 1997;20(10):585-91.
1996: J Wall; A Barsouk; Carol Stolarski; Jacek Kiljanski; I Stachura; V Nebes; K Peele; R Volpe; John S Kennerdell
Serum antibodies reactive with eye muscle antigens and the TSH receptor in a euthyroid subject who developed ophthalmopathy and Graves' hyperthyroidism.
Thyroid : official journal of the American Thyroid Association 1996;6(4):353-8.
1996: A Barsouk; K A Peele; Jacek Kiljanski; Carol Stolarski; V Nebes; John S Kennerdell; R Volpe; Jack R Wall
Antibody-dependent cell-mediated cytotoxicity against orbital target cells in thyroid-associated ophthalmopathy and related disorders; close relationship between serum cytotoxic antibodies and parameters of eye muscle dysfunction.
Journal of endocrinological investigation 1996;19(6):334-41.
1996: Jacek Kiljanski; V Nebes; Jack R Wall
Significance of tissue specific and tissue non specific autoimmune reactions of Graves' disease.
Clinical and experimental rheumatology 1996;14 Suppl 15():S69-76.
1996: Jacek Kiljanski; Carol Stolarski; A Barsouk; V Nebes; Jack R Wall
Failure to demonstrate cell-mediated immunity to orbital tissue antigens and epitopic fragments of a 64 kDa protein in the majority of patients with thyroid-associated ophthalmopathy.
Journal of endocrinological investigation 1996;19(5):284-92.
1995: Jacek Kiljanski; V Nebes; I Stachura; John S Kennerdell; Jack R Wall
Should Graves' disease be considered a collagen disorder of the thyroid, skeletal muscle and connective tissue?
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme 1995;27(12):528-32.
1995: Jack R Wall; M Hayes; D Scalise; Carol Stolarski; V Nebes; Jacek Kiljanski; Mario Salvi; M Sato
Native gel electrophoresis and isoelectric focusing of a 64-kilodalton eye muscle protein shows that it is an important target for serum autoantibodies in patients with thyroid-associated ophthalmopathy and not expressed in other skeletal muscle.
The Journal of clinical endocrinology and metabolism 1995;80(4):1226-32.
1995: Jacek Kiljanski; V Nebes; Jack R Wall
The ocular muscle cell is a target of the immune system in endocrine ophthalmopathy.
International archives of allergy and immunology 1995;106(3):204-12.